BiotechTube

glycopyrronium Topical Wipes

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hyperhidrosis

Conditions

Hyperhidrosis

Trial Timeline

Aug 1, 2015 → Apr 1, 2016

NCT ID
NCT02530294

About glycopyrronium Topical Wipes

glycopyrronium Topical Wipes is a phase 3 stage product being developed by Journey Medical for Hyperhidrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02530294. Target conditions include Hyperhidrosis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (3)

NCT IDPhaseStatus
NCT02553798Phase 3Completed
NCT02530294Phase 3Completed
NCT02530281Phase 3Completed

Competing Products

14 competing products in Hyperhidrosis

See all competitors
ProductCompanyStageHype Score
Umeclidinium + VehicleGSK plcPhase 2
51
Dose 1 of glycopyrrolate, 2.0% QD + Dose 2 of glycopyrrolate, 3.0% QD + Dose 1 of glycopyrronium, 2.5% QD + Dose 2 of glycopyrronium, 3.75% QDJourney MedicalPhase 2
44
glycopyrronium Topical WipesJourney MedicalPhase 3
69
Glycopyrronium Topical WipesJourney MedicalPhase 3
69
glycopyrrolate, 1.0% + glycopyrrolate, 2.0% + glycopyrrolate, 3.0% + glycopyrrolate, 4.0%Journey MedicalPhase 2
44
Glycopyrronium cloth, 2.4% + VehicleJourney MedicalPhase 2
44
BBI-4000 gel, 5% + BBI-4000 gel, 10% + BBI-4000 gel, 15% + Vehicle (Placebo)Botanix PharmaceuticalsPhase 2
44
BBI-4000 Gel, 5% + BBI-4000 Gel, 10% + BBI-4000 Gel, 15% + VehicleBotanix PharmaceuticalsPhase 2
44
BBI-4000, 15%Botanix PharmaceuticalsPhase 2
44
Sofpironium Bromide, 15% + VehicleBotanix PharmaceuticalsPhase 3
69
BBI-4000Botanix PharmaceuticalsPhase 1
25
Sofpironium Bromide Gel, 15% + VehicleBotanix PharmaceuticalsPhase 3
69
Sofpironium Bromide Gel, 5% + Sofpironium Bromide Gel, 15%Botanix PharmaceuticalsPhase 3
69
Sofpironium Bromide Gel, 15%Botanix PharmaceuticalsPhase 2
44

Other Products from Journey Medical

glycopyrronium Topical WipesPhase 3
69
Glycopyrronium Topical WipesPhase 3
69
Dose 1 of glycopyrrolate, 2.0% QD + Dose 2 of glycopyrrolate, 3.0% QD + Dose 1 of glycopyrronium, 2.5% QD + Dose 2 of glycopyrronium, 3.75% QDPhase 2
44
glycopyrrolate, 1.0% + glycopyrrolate, 2.0% + glycopyrrolate, 3.0% + glycopyrrolate, 4.0%Phase 2
44
Glycopyrronium cloth, 2.4% + VehiclePhase 2
44